InMed Pharmaceuticals Inc. (INM) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    InMed Pharmaceuticals Inc...

    NASDAQ: INM · Real-Time Price · USD
    2.10
    -0.06 (-2.78%)
    At close: Sep 12, 2025, 3:59 PM
    2.19
    4.29%
    After-hours: Sep 12, 2025, 05:36 PM EDT

    InMed Pharmaceuticals Ratios and Metrics

    Financials in USD. Fiscal year is July - June.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Jun 30, 2024 Jun 30, 2023 Jun 30, 2022 Jun 30, 2021
    PE Ratio
    		 -0.37 -0.43 -0.55 -4.19
    PEG Ratio
    		 0.00 0.00 0.06 0.22
    PS Ratio
    		 0.61 0.83 9.39 n/a
    PB Ratio
    		 0.42 0.38 1.45 5.79
    P/FCF Ratio
    		 -0.55 -0.61 -0.84 -4.36
    P/OCF Ratio
    		 -0.55 -0.62 -0.85 -4.37
    OCF/S Ratio
    		 -1.11 -1.33 -11.11 n/a
    Debt / Equity Ratio
    		 0.10 0.03 0.09 0.04
    Quick Ratio
    		 3.78 4.86 2.14 435.23
    Current Ratio
    		 4.41 5.66 2.89 3.78
    Asset Turnover
    		 0.53 0.39 0.11 n/a
    Interest Coverage
    		 n/a n/a n/a -27.54
    Return on Equity
    		 -1.14 -0.87 -2.64 -1.38
    Return on Assets
    		 -0.89 -0.75 -1.87 -1.04
    Return on Invested Capital
    		 -1.1 -0.89 -1.8 -1.34
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.24 0.34 0.50 n/a
    Net Profit Margin
    		 -1.67 -1.92 -17.07 n/a
    Pretax Profit Margin
    		 -1.67 -1.92 -17.07 n/a
    Operating Profit Margin
    		 -1.77 -2.03 -12.66 n/a
    FCF Margin
    		 -1.11 -1.36 -11.14 n/a
    EBITDA Margin
    		 -1.64 -1.88 -12.19 n/a

    Add to Watchlist